Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells

  • Yong Ming Zhu1Email author,
  • Nor Saadah M Azahri1,
  • Danny CW Yu1 and
  • Penella J Woll2, 3
BMC Cancer20088:218

DOI: 10.1186/1471-2407-8-218

Received: 29 June 2007

Accepted: 31 July 2008

Published: 31 July 2008

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
29 Jun 2007 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Jul 2007 Reviewed Reviewer Report - Steven Dubinett
31 Jul 2007 Reviewed Reviewer Report - Hongryull Pyo
15 Aug 2007 Reviewed Reviewer Report - John Minna
19 Mar 2008 Author responded Author comments - Yong Zhu
Resubmission - Version 3
19 Mar 2008 Submitted Manuscript version 3
16 May 2008 Reviewed Reviewer Report - Steven Dubinett
30 Jun 2008 Reviewed Reviewer Report - Andreas Bikfalvi
Resubmission - Version 4
Submitted Manuscript version 4
3 Jul 2008 Author responded Author comments - Yong Zhu
Resubmission - Version 5
3 Jul 2008 Submitted Manuscript version 5
24 Jul 2008 Author responded Author comments - Yong Zhu
Resubmission - Version 6
24 Jul 2008 Submitted Manuscript version 6
29 Jul 2008 Author responded Author comments - Yong Zhu
Resubmission - Version 7
29 Jul 2008 Submitted Manuscript version 7
Publishing
31 Jul 2008 Editorially accepted
31 Jul 2008 Article published 10.1186/1471-2407-8-218

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Institute for Cancer Studies, School of Medicine and Biomedical Science, University of Sheffield
(2)
Cancer Research Centre, Weston Park Hospital
(3)
Department of Clinical Oncology, School of Medicine and Biomedical Science, University of Sheffield

Advertisement